Header cover image

Investing Ideas
/
Swiss Pharmaceuticals & Biotech High Growth Potential Companies

Swiss Pharmaceuticals & Biotech High Growth Potential Companies

Results

12

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

12 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	SANN Santhera Pharmaceuticals Holding	CHF 8.00	-3.6%	-12.6%	CHF 96.8m	CHF 32.00	PE1.5x	E35.4%	n/a
	NWRN Newron Pharmaceuticals	CHF 7.20	-1.4%	55.8%	CHF 140.1m	CHF 14.42	PS21.6x	E56.5%	n/a
	BSLN Basilea Pharmaceutica	CHF 41.30	3.3%	16.7%	CHF 500.6m	CHF 77.25	PS3.4x	E20.1%	0%
	SDZ Sandoz Group	CHF 40.60	1.1%	53.8%	CHF 17.8b	CHF 41.71	PS2x	E34.5%	1.1%
	GALD Galderma Group	CHF 87.65	2.7%	n/a	CHF 20.8b	CHF 93.19	PS5.4x	E44.4%	n/a
	LONN Lonza Group	CHF 521.40	1.8%	48.8%	CHF 37.7b	CHF 631.85	PE65.7x	E23.9%	0.8%
	COPN Cosmo Pharmaceuticals	CHF 62.80	-1.3%	58.4%	CHF 1.0b	CHF 97.30	PE15.6x	E17.2%	3.0%
	PPGN PolyPeptide Group	CHF 27.95	-3.0%	48.9%	CHF 921.9m	CHF 36.25	PS3.1x	E64.2%	0%
	SKAN SKAN Group	CHF 73.10	0%	-9.9%	CHF 1.6b	CHF 90.00	PE51x	E18.7%	0.5%
	TECN Tecan Group	CHF 210.00	0.2%	-32.8%	CHF 2.7b	CHF 286.14	PE26.6x	E14.9%	1.4%
	BANB Bachem Holding	CHF 67.50	-2.0%	-4.3%	CHF 5.1b	CHF 84.43	PE44.6x	E17.9%	1.2%
	SFZN Siegfried Holding	CHF 1,114.00	3.7%	40.2%	CHF 4.8b	CHF 1,187.67	PE37.1x	E13.6%	0.3%

Page 1 of 1